ResMed (NYSE: RMD)
ResMed Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
ResMed Company Info
ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.
News & Analysis
ResMed Tops Estimates in Fiscal 2025 Q1
ResMed posted robust revenue and earnings growth but faces operational cost pressure due to rising expenses.
Best Medical Device Stocks to Buy for 2024
Why ResMed Stock Tumbled by 5% Today
A looming threat from a very powerful rival could significantly dampen a key business for the company.
These Are Billionaires’ Favorite Healthcare Stocks
The Motley Fool analyzed 16 billionaire-led hedge funds to get an idea of their healthcare sector investment strategies.
Why ResMed Stock Is Soaring Today
Investors liked the healthcare technology company's latest quarterly update.
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode.
Why ResMed Stock Is Jumping Today
The medical device maker beat expectations with its latest quarterly results.
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
Mick Farrell might be kidding himself about the degree to which the popular weight-loss drugs will impact his company.
Valuation
Podcast Episodes
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
We also talk about weight loss drugs and sleep apnea, and other stock market news.
Is Resmed a Buy?
The CPAP pioneer has a phenomenal track record of success, but should investors jump on board today?
Earnings Transcripts
ResMed (RMD) Q4 2022 Earnings Call Transcript
RMD earnings call for the period ending June 30, 2022.
ResMed (RMD) Q3 2022 Earnings Call Transcript
RMD earnings call for the period ending March 31, 2022.
ResMed (RMD) Q2 2022 Earnings Call Transcript
RMD earnings call for the period ending December 31, 2021.
ResMed (RMD) Q1 2022 Earnings Call Transcript
RMD earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.